Literature DB >> 12871297

Signaling events underlying thrombus formation.

S P Jackson1, W S Nesbitt, S Kulkarni.   

Abstract

Recent in vivo studies have highlighted the dynamic and complex nature of platelet thrombus growth and the requirement for multiple adhesive receptor-ligand interactions in this process. In particular, the importance of von Willebrand factor (VWF) in promoting both primary adhesion and aggregation under high shear conditions is now well established. In general, the efficiency with which platelets adhere and aggregate at sites of vessel wall injury is dependent on the synergistic action of various adhesive and soluble agonist receptors, with the contribution of each of the individual receptors dependent on the prevailing blood flow conditions. In this review, we will discuss the major platelet adhesive interactions regulating platelet thrombus formation under high shear, with specific focus on the VWF (GPIb and integrin alphaIIbbeta3) and collagen receptors (GPVI and integrin alpha2beta1). We will also discuss the signaling mechanisms utilized by these receptors to induce platelet activation with specific emphasis on the role of cytosolic calcium flux in regulating platelet adhesion dynamics. The role of soluble agonists in promoting thrombus growth will be highlighted and a model to explain the synergistic requirement for adhesive and soluble stimuli for efficient platelet aggregation will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871297     DOI: 10.1046/j.1538-7836.2003.00267.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  96 in total

Review 1.  Central role of the P2Y12 receptor in platelet activation.

Authors:  Robert T Dorsam; Satya P Kunapuli
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 2.  Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy.

Authors:  Zhongheng Zhang; Ni Hongying
Journal:  Intensive Care Med       Date:  2011-11-29       Impact factor: 17.440

Review 3.  Endothelial Repair and Regeneration Following Intimal Injury.

Authors:  Belay Tesfamariam
Journal:  J Cardiovasc Transl Res       Date:  2016-01-21       Impact factor: 4.132

4.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.

Authors:  Nicolas Prévost; Donna S Woulfe; Hong Jiang; Timothy J Stalker; Patrizia Marchese; Zaverio M Ruggeri; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

5.  [In vitro testing of thrombocyte adhesion to different collagenous hemostyptic agents].

Authors:  D Rothamel; F Schwarz; V Stoldt; M Herten; C Kotthaus; J Becker
Journal:  Mund Kiefer Gesichtschir       Date:  2006-05

Review 6.  12-lipoxygenase: a potential target for novel anti-platelet therapeutics.

Authors:  Jennifer Yeung; Michael Holinstat
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2011-07-01

7.  Role of FcRgamma and factor XIIIA in coated platelet formation.

Authors:  Shawn M Jobe; Lorie Leo; Joshua S Eastvold; Gerhard Dickneite; Timothy L Ratliff; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

8.  Expression profiling and electrophysiological studies suggest a major role for Orai1 in the store-operated Ca2+ influx pathway of platelets and megakaryocytes.

Authors:  Gwen Tolhurst; Richard N Carter; Stefan Amisten; Jon P Holdich; David Erlinge; Martyn P Mahaut-Smith
Journal:  Platelets       Date:  2008-06       Impact factor: 3.862

9.  Eptifibatide: The evidence for its role in the management of acute coronary syndromes.

Authors:  Ibrahim Shah; Shakeel O Khan; Surender Malhotra; Tim Fischell
Journal:  Core Evid       Date:  2010-06-15

10.  Protein kinase Ctheta negatively regulates store-independent Ca2+ entry and phosphatidylserine exposure downstream of glycoprotein VI in platelets.

Authors:  Matthew T Harper; Alastair W Poole
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.